Pulmonary Hypertension

Pulmonary hypertension is high blood pressure in the arteries leading from the heart to the lungs. These arteries become hard and narrow, forcing the heart to work harder to pump blood through. Symptoms include shortness of breath, chest pain, a racing heartbeat, and fatigue.

Quick Answer

What it is

Pulmonary hypertension is high blood pressure in the arteries leading from the heart to the lungs. These arteries become hard and narrow, forcing the heart to work harder to pump blood through.

Key findings

  • Grade B: Pulmonary Hemodynamics (Vasoactive Intestinal Peptide (VIP/Aviptadil))
  • Grade C: Blood Pressure (Citrulline)
  • Grade N/A: Exercise Capacity (Citrulline)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Pulmonary Hypertension

  • Supplements Studied:2
  • Research Trials:1
  • Total Participants:25
  • Top Supplement:Citrulline (C)
1 trials
25 ppts
2 supps · 3 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

100-300mg daily

Supports cardiac energy production; antioxidant; may help with exercise tolerance and heart function

6 studies | 250 participants
IV iron if deficient (oral often inadequate); dosing per physician

Iron deficiency very common in PAH and worsens exercise capacity; supplementation improves symptoms

10 studies | 500 participants

Supporting Stack (Tier 2)

2-3g EPA+DHA daily

Anti-inflammatory; may support vascular health and reduce inflammation

5 studies | 200 participants
2000-4000 IU daily (monitor levels)

Deficiency common in PAH; may support immune function and vascular health

6 studies | 300 participants
3-6g daily (ONLY under physician supervision)

Nitric oxide precursor; may support vasodilation (use with caution - discuss with physician)

8 studies | 300 participants
300-400mg daily

Supports cardiovascular function; vasodilator properties; often depleted in heart failure

5 studies | 200 participants
1-2g daily

Supports cardiac energy metabolism; may help with exercise tolerance

4 studies | 150 participants
B-complex with methylated B12 and folate daily

Support energy metabolism; B12 and folate important for homocysteine metabolism

4 studies | 150 participants
1-3g daily

Supports cardiac function; antioxidant; may have mild vasodilatory effects

4 studies | 150 participants

How It Works

Pulmonary hypertension (PH) is high blood pressure in the blood vessels of the lungs. Unlike regular high blood pressure (systemic), PH specifically affects the pulmonary arteries. This increases the workload on the right side of the heart, which can eventually lead to right heart failure. Symptoms include shortness of breath (especially with exertion), fatigue, chest pain, dizziness, leg swelling, and racing heartbeat.

CRITICAL: Pulmonary hypertension is a serious, life-threatening condition requiring specialist care from a pulmonologist and/or cardiologist experienced in PH. There are 5 groups of PH with different causes and treatments:

Group 1 (PAH): Pulmonary arterial hypertension - treated with targeted therapies
Group 2: Due to left heart disease
Group 3: Due to lung disease/hypoxia
Group 4: Chronic thromboembolic (CTEPH)
Group 5: Unclear/multifactorial

MEDICAL TREATMENT IS ESSENTIAL. For Group 1 PAH, approved therapies include: phosphodiesterase inhibitors (sildenafil, tadalafil), endothelin receptor antagonists (bosentan, ambrisentan), prostacyclin analogs (epoprostenol, treprostinil), and soluble guanylate cyclase stimulators (riociguat). Treatment is complex and often involves combination therapy.

These supplements are SUPPORTIVE ONLY and must be discussed with your PH specialist:

* Iron deficiency is extremely common in PAH (affecting 40-60% of patients) and independently worsens exercise capacity. IV iron replacement (oral often ineffective) can significantly improve symptoms.

* Coenzyme Q10 supports heart energy production.

* Omega-3 Fatty Acids may support vascular health.

* L-Arginine is a nitric oxide precursor - use ONLY under physician supervision as it can interact with PH medications.

* Magnesium and L-Carnitine support cardiovascular function.

Expected outcomes: These supplements may provide modest supportive benefit but DO NOT replace medical therapy. Work closely with your PH specialist team.

Generated from peer-reviewed researchSchema v2.0

Supplements for Pulmonary Hypertension

Sorted by strength of evidence

Detailed Outcomes

B
Pulmonary Hemodynamics
Petkov 2003: Inhaled VIP reduced pulmonary artery pressure, improved cardiac output and mixed venous oxygen in PAH patients. VIP deficiency found in PAH patient serum and lung tissue. Small clinical studies show promise.
moderateImproves
C
Blood Pressure
Small Improvement
1 study
smallImproves
?
Exercise Capacity
1 study
Improves

Research Citations (98)

Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis.
(2025)
PMID: 41368449
Aviptadil as a Promising Intervention: A Case Study for Transfusion-Related Acute Lung Injury Treatment in a Cardiac Patient.
(2024)
PMID: 38458826
Vasoactive Intestinal Polypeptide for Patients Hospitalized With COVID-19 and Hypoxemic Respiratory Failure: Effect on Mortality-The TESICO Trial
(2023)
PMID: 37328169
Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice.
(2023)
PMID: 36650220
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
(2023)
PMID: 37348524
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial
(2022)
PMID: 36193478
Brief Report: Rapid Clinical Recovery From Critical Coronavirus Disease 2019 With Respiratory Failure in a Pregnant Patient Treated With IV Vasoactive Intestinal Peptide.
(2022)
PMID: 35018346
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.
(2022)
PMID: 36044317
Editorial: GPCR in Inflammatory and Cancer Diseases.
(2020)
PMID: 33101216
Vasoactive Intestinal Peptide Changes the Frequency and Force of Myocardial Contraction in Rats.
(2020)
PMID: 33098516

Related Conditions

Type 2 Diabetes

1 shared supplement · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Tennis Performance

1 shared supplement · 5 outcomes

Tennis performance refers to the ability to execute the skills and meet the physiological demands of the sport of tennis.

Rheumatoid Arthritis (RA)

1 shared supplement · 67 outcomes

Rheumatoid arthritis (RA) is an autoimmune disease that is mainly known for affecting the joints, but can also affect other parts of the body. It is more common in women than men and often starts during middle age, but it can occur at any age. The cause of RA is not well understood, but it seems to involve genetic, environmental, and hormonal factors.

Obesity

1 shared supplement · 525 outcomes

Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.

Nonalcoholic Fatty Liver Disease (NAFLD)

1 shared supplement · 221 outcomes

Non-alcoholic fatty liver disease (NAFLD) is a condition in which excessive fat (more than 5% of liver weight) accumulates in the liver due to causes unrelated to alcohol.

1 shared supplement · outcomes

Muscle Size & Strength

1 shared supplement · 334 outcomes

This page on muscle size and strength covers strategies to maximize muscle gain and strength gain. There is notable overlap in nutrition and supplementation strategies to facilitate these two goals, but there is some divergence in the best type of exercise. A larger muscle tends to be a stronger muscle.

Muscle Recovery

1 shared supplement · 219 outcomes

Muscle recovery refers to a reduction in muscle soreness or a return of a muscle’s range of motion, strength, or power to normal levels after fatiguing exercise or muscle damage. Muscle recovery is associated with reductions in markers of muscle damage and inflammation.